Research
Hormonal
Semaglutide can be used safely and efficiently in non-diabetic people with excess weight.
Semaglutide may be considered as a treatment option for weight management in non-diabetic patients.
StrongSupportsmedium confidence
Semaglutide is the second marketed glucagon-like peptide 1 receptor agonist that can be used safely and efficiently in non-diabetic people with excess weight.
Why this rating
The claim is based on a review of relevant clinical studies.
Source
Semaglutide and obesity: beyond the nutritional and lifestyle intervention?
Livia Basile et al. · Minerva Endocrinology · 2024
reviewCited 7×
Read the paper This is one finding among thousands. Every one is graded and traced to its source, so you can see what the evidence actually supports. Browse the research →